Cognition Therapeutics (NASDAQ:CGTX) Given Buy Rating at Chardan Capital
Cognition Therapeutics (NASDAQ:CGTX – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Chardan Capital in a note issued to investors on Wednesday,Benzinga reports. They presently have a $11.00 price objective on the stock. A number of other equities analysts also recently weighed in on the company. HC Wainwright upped […]
Cognition Therapeutics (NASDAQ:CGTX – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Chardan Capital in a note issued to investors on Wednesday,Benzinga reports. They presently have a $11.00 price objective on the stock. A number of other equities analysts also recently weighed in on the company. HC Wainwright upped […]
